Physician profile
James T Lin
NPI 1821009580
$16,915.92
in general payments reported to CMS, 2019-2025
54 companies · $2,398 in 2025
The $2,398 reported for 2025 was more than what 97% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,580 · 2020: $1,707 · 2021: $2,621 · 2022: $2,032 · 2023: $1,980 · 2024: $3,598 · 2025: $2,398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,976.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,975.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,870.50 | 2021-2025 | |
| Medtronic, INC. | $1,468.89 | 2022-2024 | Accurian, Synchromedii, Intellis Adaptivestim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,433.25 | 2019-2025 | Relistor |
| Collegium Pharmaceutical, INC. | $1,409.96 | 2019-2025 | Belbuca, Xtampza |
| Lumenis Be INC | $1,304.66 | 2024 | M22 |
| Relievant Medsystems, INC. | $1,161.59 | 2021-2023 | Intracept |
| Biotronik Nro, INC. | $1,102.28 | 2025 | Prospera |
| Scilex Pharmaceuticals INC. | $578.38 | 2019-2025 | Ztlido |
| Teva Pharmaceuticals USA, INC. | $434.66 | 2019-2023 | Ajovy |
| Boston Scientific Corporation | $383.38 | 2019-2024 | Intracept |
| Arbor Pharmaceuticals, INC. | $336.61 | 2020-2021 | |
| Azurity Pharmaceuticals, INC. | $332.48 | 2023-2025 | Horizant, Horizant |
| Allergan, INC. | $329.15 | 2020-2022 | |
| Pfizer INC. | $326.51 | 2019-2025 | |
| Lilly USA, LLC | $322.73 | 2019-2024 | Emgality, Reyvow |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.